NRSN (NeuroSense Therapeutics) Float Percentage Of Total Shares Outstanding: 77.57% (As of Jun. 26, 2026)


NRSN NeuroSense Therapeutics Ltd NRSN
29 GF Score
Price $0.74
! 2 Warning Signs
View Full Analysis

What is NeuroSense Therapeutics Float Percentage Of Total Shares Outstanding?

NeuroSense Therapeutics NRSN -2.50% 29 Float Percentage Of Total Shares Outstanding is 77.57% as of Jun. 26, 2026. GuruFocus rates NRSN with a GF Score™ of 29/100. The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NeuroSense Therapeutics's float shares is 28.00 Mil. NeuroSense Therapeutics's total shares outstanding is 36.10 Mil. NeuroSense Therapeutics's float percentage of total shares outstanding is 77.57%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NeuroSense Therapeutics's Insider Ownership is 4.58%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NeuroSense Therapeutics's Institutional Ownership is 1.07%.

NRSN
29GF Score
NeuroSense Therapeutics Ltd NRSN
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeuroSense Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

NeuroSense Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=28.00/36.10
=77.57%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 77.57% mean?
NeuroSense Therapeutics (NRSN) has a Float Percentage Of Total Shares Outstanding of 77.57% as of Jun. 26, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on NeuroSense Therapeutics and its competitors.
Is NeuroSense Therapeutics' Float Percentage Of Total Shares Outstanding too high?
NeuroSense Therapeutics' current Float Percentage Of Total Shares Outstanding is 77.57%. Overall, NeuroSense Therapeutics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does NeuroSense Therapeutics' Float Percentage Of Total Shares Outstanding compare to SNTI and LSTA?
NeuroSense Therapeutics' Float Percentage Of Total Shares Outstanding of 77.57% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on NeuroSense Therapeutics and its competitors. NeuroSense Therapeutics's current Float Percentage Of Total Shares Outstanding is 77.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeuroSense Therapeutics stock overvalued right now?
NeuroSense Therapeutics (NRSN) has a current Float Percentage Of Total Shares Outstanding of 77.57%. The current Float Percentage Of Total Shares Outstanding is 77.57%. NeuroSense Therapeutics' overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For NeuroSense Therapeutics (NRSN), the current Float Percentage Of Total Shares Outstanding is 77.57% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NeuroSense Therapeutics Business Description

Other Exchanges H1Z:Germany
Address 11 HaMenofim Street, Building B, Herzliya, ISR, 4672562
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
29GF Score

Get the complete analysis for NRSN

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.74
Price